Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

California Healthline Explains Why It is OK that a JAMA Study Found No Savings in Medical Homes

The patient-centered medical home model seems to make intuitive sense as a way to reduce waste in health care. Therefore, it came as a shock to many when the Journal of the American Medical Association published research showing that adopting this model actually didn’t make much of a difference in costs or outcomes.

ATA to Sebelius: 'End unnecessary restrictions'

The American Telemedicine Association has asked Department of Health and Human Services Secretary Kathleen Sebelius to lift "unnecessary restrictions" on healthcare delivery that prohibits millions of Americans from accessing quality medical care."

ATA to Co-Host Chinese Telemedicine Conference and Exhibition in Tianjin

In a significant development signaling the world-wide growth of telemedicine, the American Telemedicine Association (ATA) today announced it will co-host the first telemedicine technology exhibition at the Binhai International Convention and Exhibition Center in Tianjin, China, outside of Beijing, Oct. 28-30, 2014. Over 5,000 attendees and 500 exhibitors are expected to attend this inaugural event. The meeting has official approval of the government and is co-hosted by the Municipal Government of Tianjin Binhai New Area as well as the Tianjin Public Health Bureau and Medical Association. Information on registration and exhibiting will be available May 2014.

Thumbnail

ACPE survey: Growing acceptance of employed physicians

Thanks to improved communication, greater transparency, better physician job satisfaction and a more patient-centered focus, more healthcare leaders and the physicians they employ approve of the integrated physician model , according to a survey conducted by the American College of Physician Executives.

The VNA Institute of Technology Hosts Clinical Interoperability Symposium in San Francisco March 24th

(March 5, 2014 - MILWAUKEE, WI) The VNA Institute of Technology invites all healthcare IT professionals to Challenges and Opportunities of Clinical Interoperability, an informative IT symposium in San Francisco, CA on Monday, March 24th.  The event brings together notable IT leaders from the University of Texas M.D. Anderson Cancer Center, Stanford Hospital and Clinics, and The Advisory Board Company to discuss key issues in clinical image interoperability across the enterprise.  Radiologists, cardiologists, hospital executives, CIOs, IT managers and more will attend this unique event.  Attendees are not required to belong to VNAIT to attend, but may subscribe to VNAIT.org by Clicking Here to earn free CPHIMS CE hours.

Thumbnail

Penn. health system, MinuteClinic to integrate EHRs, collaborate on care

Main Line Health (MLH), a Penn-based health system, and MinuteClinic, CVS’s retail healthcare division, have signed an agreement in which MLH’s network of more than 2,000 doctors will serve as collaborating physicians for MinuteClinic locations in Chester, Delaware and Montgomery counties.

Telemedicine reduced hospitalizations of nursing home patients

Nursing homes that offered telemedicine after hours significantly reduced the hospitalization rate of their patients compared to facilities that did not offer this service, according to a Commonwealth Fund-supported study published in Health Affairs.

Kaiser Permanente offers free video physician visits

Kaiser Permanente is betting on mobile health and telehealth to reduce unnecessary and costly visits to urgent care centers and hospitals.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.